Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Study on the Safety and Effectiveness of RGN-259 Eye Drops for Patients with Neurotrophic Keratopathy
GermanyStudy on PRAX-628 for Epilepsy Patients with Light-Induced EEG Response
The NetherlandsStudy on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy
AustriaStudy on the Safety and Effectiveness of MK-1942 for Patients with Mild to Moderate Alzheimer's Disease
ItalyStudy on Cannabidiol for Reducing Seizures in Children and Young Adults with Severe Epilepsy Associated with Rare Diseases
ItalyStudy on Cladribine for Patients with Multiple Sclerosis to Evaluate Brain Network Changes
SpainStudy on the Effects of ABBV-552 in Patients Aged 50-90 with Mild Alzheimer's Disease
GermanyStudy on Ganaxolone for Children and Adults with Epilepsy Related to Tuberous Sclerosis Complex
BelgiumStudy on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy
AustriaStudy on the Safety and Tolerability of VGL101 for Adults with Adult-Onset Leukoencephalopathy
FranceStudy on Neflamapimod for Treating Dementia with Lewy Bodies in Patients Aged 55 and Older
The NetherlandsStudy on GSK3858279 for Adults with Chronic Diabetic Nerve Pain
FranceThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
